HELA 3.0
associated with 34 other trademarks
Chemical, biological, and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonu...

Words that describe this trademark:

nucleic acids  gene delivery  biochemical products  chemical biological  delivery technology  including  technology  products  acids  biological 

Serial Number:

90718951

Mark:

HELA 3.0

Status:

Abandoned-Failure to Respond

Status Date:

10-13-2022

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Chemical, biological, and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, for in vitro laboratory use and in vivo therapeutic use in gene therapy; chemical, biological, and biochemical products for use in the manufacture of pharmaceutical preparations Licensing of intellectual property Providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of genetic diseases and disorders; providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of liver, hepatological, cardiovascular, central nervous system, endocrine, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, respiratory, and hematologic diseases and disorders; medical information services in the nature of providing a database in the field of gene therapy information based on collected patient data and information all for treatment and diagnostic purposes; medical information services Research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; conducting clinical trials for others in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; gene therapy design and delivery development of biochemical assays; compiling and sharing of patient data for research purposes in the field of medical science

Mark Description:

N/A

Class:

Legal services

Type of Mark:

Trademark

Published for Opposition Date:

N/A

Mark Drawing Status:

Standart Character Mark

Abandon Date:

10-03-2022

Business Name:

COOLEY LLP

Correspondent Name:

Recent Trademark filings by this company